Desmethoxyfallypride

Desmethoxyfallypride is a moderate affinity dopamine D2 receptor/D3 receptor antagonist used in medical research, usually in the form of the radiopharmaceuticals desmethoxyfallypride or DMFP(18F)[1][2] and has been used in human studies[3][4] as a positron emission tomography (PET) radiotracer.

Desmethoxyfallypride (18F)
Clinical data
Other namesDMFP (18F)
Pregnancy
category
  • N/A
ATC code
  • none
Legal status
Legal status
  • Research compound
Identifiers
PubChem CID
ChemSpider
Chemical and physical data
FormulaC19H27FN2O2
Molar mass334.435 g·mol−1
3D model (JSmol)

References

  1. Mukherjee J, Yang ZY, Brown T, Roemer J, Cooper M (1996). "18F-desmethoxyfallypride: a fluorine-18 labeled radiotracer with properties similar to carbon-11 raclopride for PET imaging studies of dopamine D2 receptors". Life Sciences. 59 (8): 669–78. doi:10.1016/0024-3205(96)00348-7. PMID 8761017.
  2. Leung, K. (2004). "(S)-N-((1-Allyl-2-pyrrolidinyl)methyl)-5-(3-18Ffluoropropyl)-2-methoxybenzamide". PMID 20641474. Cite journal requires |journal= (help)
  3. Gründer G, Siessmeier T, Piel M, Vernaleken I, Buchholz HG, Zhou Y, et al. (January 2003). "Quantification of D2-like dopamine receptors in the human brain with 18F-desmethoxyfallypride". Journal of Nuclear Medicine. 44 (1): 109–16. PMID 12515884.
  4. Siessmeier T, Zhou Y, Buchholz HG, Landvogt C, Vernaleken I, Piel M, et al. (June 2005). "Parametric mapping of binding in human brain of D2 receptor ligands of different affinities". Journal of Nuclear Medicine. 46 (6): 964–72. PMID 15937307.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.